Search Results 1381-1390 of 19369 for hemoglobin

1. Regorafenib in Metastatic Colorectal Cancer - Mayo Clinic

   Platelet count ≥ 100,000, hemoglobin ≥ 9 g/dL; Absolute neutrophil count ≥ 1,500. Blood transfusion to meet the inclusion criteria not be allowed ...

2. A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP) - Mayo Clinic

   Hemoglobin A1C > 7%, confirmed by repeat testing;; Positive blood screen for human immunodeficiency virus (HIV), hepatitis C antibody, or hepatitis B surface ...

3. A Study to Test the Addition of Nivolumab to Chemotherapy to Treat Soft Tissue Sarcoma - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL. Calculated (Calc.) creatinine clearance ≥ 30 mL/min (per Cockcroft-Gault). Total bilirubin ≤ 1.5 x upper limit of normal (ULN) ...

4. A Study to Evaluate Lenalidomide and Dexamethasone, with or without Daratumumab, in Treating High-Risk Smoldering Myeloma Patients - Mayo Clinic

   Hemoglobin ≥ 11 g/dL;; Platelet count ≥ 100,000 cells/mm^3;; Absolute neutrophil count ≥ 1500 cells/mm^3;; Calculated creatinine clearance ≥ 30 mL/min ...

5. Veliparib and Topotecan Hydrochloride in Treating Patients with Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL; Platelets ≥ 100,000/mcL; Total bilirubin ≤ 1.5x the upper limit of normal (ULN); Serum glutamic pyruvic transaminase (SGPT) (alanine ...

6. Postoperative Care Clinical Trials - Mayo Clinic Research

   ... hemoglobin monitoring compared to invasive blood draw, and to evaluate cost effectiveness of noninvasive monitoring in comparison to invasive blood draws.

7. Bortezomib, Melphalan, and Total-Body Irradiation Before Stem Cell Transplant in Treating Patients With Multiple Myeloma - Mayo Clinic

   Hemoglobin ≥ 8.0 g/dL; Diagnosis of myeloma for which autologous stem cell transplant is being considered; Measurable disease of multiple myeloma at the time ...

8. A Study to Evaluate the Safety, Effectiveness, and Tolerability of Latiglutenase to Treat Patients with Well-Controlled Celiac Disease - Mayo Clinic

   Hemoglobin < 10 g/dL or 100 g/L;; Calcium < 8.0 mg/mL;; Platelet count< 75.0 x 109/L or 75,000/mm3;; Partial thromboplastin time (PTT) or prothrombin time (PT ...

9. Sunitinib Malate with or without Gemcitabine Hydrochloride in Treating Patients with Advanced Kidney Cancer that Cannot be Removed by Surgery - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL (transfusions allowed); Serum creatinine clearance ≥ 30 mL/min; SGOT and SGPT ≤ 2.5 times ULN (≤ 5 times ULN in the presence of ...

10. A Study to Evaluate RGLS4326 to Treat Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

    Hemoglobin > 12 g/dL for females and > 13.5 g/dL for males;; Total and direct bilirubin < 1.5 x upper limit of normal (ULN), unless elevated bilirubin is ...